Trademarkia Logo

Canada

C$
MERXIN DESIGN
REGISTERED

on 18 Jan 2022

Last Applicant/ Owned by

MERXIN LTD

King's Lynn Innovation Centre1 Innovation WayKing's LynnNorfolk PE30 5BY

GB

Serial Number

1876444 filed on 8th Jan 2018

Registration Number

TMA1117903 registered on 18th Jan 2022

Registration expiry Date

18th Jan 2032

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

MERXIN DESIGN

Trademark usage description

pharmaceuticals for treating viral diseases and disorders, namely herpes, hepatitis, acquired immune deficiency syndrome (aids), metabolic diseases an Read More

Vienna Information


2 . 1 . 17

Men seated, kneeling or lying downHommes assis, agenouillés ou étendus

2 . 1 . 23

Men stylized -- Note: Including stick figures of men.Hommes stylisés -- Note: Y compris les bonshommes-allumettes d'hommes.

2 . 1 . 30

Other menAutres hommes

26 . 1 . 2

EllipsesEllipses

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 5 . 21

One letterUne lettre

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information


Class [005]
Pharmaceuticals for treating viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), metabolic diseases and disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, endocrine diseases and disorders, namely growth and thyroid disorders, musculoskeletal diseases and disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, cardiovascular, cardiopulmonary, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, sexual dysfunction, oncological, hepatological diseases and disorders, namely liver, gallbladder, biliary tree, and pancreas diseases and disorders, ophthalmic, respiratory, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders, gastrointestinal, hormonal diseases and disorders, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders and immune system diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical compositions for treating viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), metabolic diseases and disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, endocrine diseases and disorders, namely growth and thyroid disorders, musculoskeletal diseases and disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, cardiovascular, cardiopulmonary, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, sexual dysfunction, oncological, hepatological diseases and disorders, namely liver, gallbladder, biliary tree, and pancreas diseases and disorders, ophthalmic, respiratory, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders, gastrointestinal, hormonal diseases and disorders, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders and immune system diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for treating viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), metabolic diseases and disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, endocrine diseases and disorders, namely growth and thyroid disorders, musculoskeletal diseases and disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, cardiovascular, cardiopulmonary, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, sexual dysfunction, oncological, hepatological diseases and disorders, namely liver, gallbladder, biliary tree, and pancreas diseases and disorders, ophthalmic, respiratory, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders, gastrointestinal, hormonal diseases and disorders, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders and immune system diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for inhalers namely, medical pharmaceutical compositions for treating viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), metabolic diseases and disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, endocrine diseases and disorders, namely growth and thyroid disorders, musculoskeletal diseases and disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, cardiovascular, cardiopulmonary, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, sexual dysfunction, oncological, hepatological diseases and disorders, namely liver, gallbladder, biliary tree, and pancreas diseases and disorders, ophthalmic, respiratory, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders, gastrointestinal, hormonal diseases and disorders, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders and immune system diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes structured for delivery into the body by nebulizer, aerosol, or dry powder, via the lungs or via the nasal passageway; Veterinary preparations for treating viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), infectious, metabolic diseases and disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, endocrine diseases and disorders, namely growth and thyroid disorders, musculoskeletal diseases and disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, cardiovascular, cardiopulmonary, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, oncological, hepatological diseases and disorders, namely liver, gallbladder, biliary tree, and pancreas diseases and disorders, ophthalmic, respiratory, gastrointestinal, hormonal diseases and disorders, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, and immune system diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, and vitamin deficiencies; Dietary supplements and dietetic preparations for general health and well-being


Classification kind code

11

Class [009]
Laboratory equipment for scientific purposes, namely vials.


Classification kind code

11

Class [010]
Medical applicators for facilitating the inhalation of pharmaceutical preparations; Medical syringes sold empty for administering pharmaceuticals; Inhalers for medical purposes sold empty; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Inhalers for therapeutic use; Medical inhalers sold empty; Medical Apparatus for measuring lung function, namely spirometers for examining the function of the lungs; Spirometers for examining the function of the lungs; Breath gas analysers for medical diagnostics; Parts and fittings for all the aforesaid goods namely spirometer mouth pieces and tubing, breath gas analyzers for medical diagnostics, replacement cartridges for medical inhalers sold empty, nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of asthma and respiratory diseases


Classification kind code

11

Class [042]
Scientific and technological services, namely, research and design in the field of drug delivery via the lungs or via the nasal passageway; Scientific and technological design of new products for others; Advisory services relating to design of new products for others; Advisory services relating to testing of new products for others; Product design and development; New product design services, namely, analysis and evaluation of product design; New product design and consultancy services; Professional consultancy relating to medical technology; project management services in the field of medical and pharmaceutical engineering, not for business purposes; Scientific research in the field of medical and pharmaceutical engineering; Pharmaceutical research and development services; Research and development for the pharmaceutical industry; Research relating to medicines.


Classification kind code

11

Class [044]
Pharmaceutical consultation; Pharmaceutical advisory services; Veterinary services.


Classification kind code

11

Mark Details


Serial Number

1876444

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 27
on 24th Mar 2021
Approval Notice Sent
Submitted for opposition 26
on 24th Mar 2021
Approved
Submitted for opposition 12
on 17th Jul 2020
Extension of Time
Submitted for opposition 15
on 29th Nov 2019
Correspondence Created
Submitted for opposition 22
on 14th Mar 2019
Search Recorded
Submitted for opposition 20
on 14th Mar 2019
Examiner's First Report
Submitted for opposition 135
on 16th Apr 2018
Amendment to Application
Submitted for opposition 31
on 11th Jan 2018
Formalized
Submitted for opposition 1
on 9th Jan 2018
Created
Submitted for opposition 30
on 8th Jan 2018
Filed